Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Screening and verification of antiviral compounds against HSV-1 using a method based on a plaque inhibition assay

Fig. 3

Percent inhibition of 11 candidate inhibitors against HSV-1 and dose-response effects of five inhibitors(a) Percent inhibition at the concentration of 100 µM. This is based on results of plaque reduction assay. This concentration is also used in first-round screening. (b-g) Dose-response curves of five inhibitors. A log transformation of these concentrations has been conducted

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us